Important pharmacy news and late-breaking industry information updated daily.

“What is your story? How does it fit with the profession’s story?” APhA President-elect Brad Tice, PharmD, MBA, FAPhA, asked the audience at Sunday’s Second General Session of APhA2019. Tice, senior vice president for Aspen RxHealth and CEO of RxGenomix, will be installed here in Seattle as the 164th APhA President.

On Friday, delegates gathered at Washington State Convention Center for the first session of the APhA House of Delegates during the 2019 APhA Annual Meeting & Exposition. The House of Delegates—which comprises representatives from state pharmacy associations, APhA membership academies, affiliated organizations, recognized pharmacy organizations, and ex-officio groups—develops official APhA policy affecting the pharmacy profession and patient care. 

Despite major efforts in the past three decades to decrease improper antibiotic prescribing and reduce the risk of antibiotic resistance, antibiotics are still being prescribed inappropriately in the outpatient setting. A recent BMJ article found that about 23% of antibiotics were prescribed for a diagnosis that does not warrant a prescription antibiotic.

Eli Lilly says the net price for its most popular insulin, insulin lispro recombinant (Humalog) fell to an average of $135 a patient a month in 2018 after discounts and rebates, from $147 in 2014. During the same period, the product's average list price rose 51.9% to $594 per patient monthly.

In helping with those struggling with thoughts of suicide, “pharmacists are first responders,” said 2019 APhA Annual Meeting & Exposition Opening General Session keynote speaker Kevin Briggs, a retired sergeant with the California Highway Patrol. Briggs delivered his remarks to APhA2019 Opening General Session attendees in Seattle on March 23.  

The 20th annual APhA Federal Pharmacy Forum’s opening ceremony and education sessions were held in conjunction with the 2019 APhA Annual Meeting & Exposition in Seattle on Friday, March 22. Approximately 150 pharmacists and pharmacy technicians attended from the U.S. Army (USA), Navy (USN), Air Force (USAF), Coast Guard (USCG), Public Health Service (USPHS), Indian Health Service (IHS), U.S. Department of Veterans Affairs (VA), and Federal Bureau of Prisons (BOP). Student pharmacists and others also attended, and approximately 34 supporting industry partners exhibited.

FDA should issue a moratorium on new opioid analgesic approvals, according to the advocacy group Public Citizen. In a letter to FDA Commissioner Scott Gottlieb and HHS Secretary Alex Azar, the group asserts that, along with the industry itself, "it is beyond question that the FDA is also culpable." The letter—signed by Sidney M.

FDA said Wednesday that it will temporarily allow certain manufacturers to sell losartan containing N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the interim acceptable intake limit of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.

FDA approved on Tuesday brexanolone (Zulresso—Sage Therapeutics) injection for I.V. use for the treatment of postpartum depression (PPD) in adults women.

Taking a low-dose (75–100 mg) aspirin daily is no longer recommended for heart disease and stroke prevention among healthy older adults, according to the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease, published on March 17.